WHO has made available the membership of the Guidelines Development Group (GDG) for the update of the WHO guidelines on “The diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children; supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection.” These guidelines will update existing recommendations on preferred and alternative induction therapy for management of cryptococcal disease and are supplement the WHO consolidated guidelines on HIV, 2021.
The virtual meeting of the clinical GDG will be held on 2 February 2022.
The objective of this guidelines meeting is to formulate recommendations on preferred and alternative induction therapy for the management of cryptococcal disease in people living with HIV.
In line with WHO policy on conflict of interest, members of the public and interested organizations can access the biographies of the GDG members and inform WHO of their views about them. All comments should be sent by email to [email protected] by 1 February 2022.
